| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/26/2011 | EP2276504A1 Vascular aging inhibitor and anti-aging formulation |
| 01/26/2011 | EP2276503A2 Citrullinated cytokines |
| 01/26/2011 | EP2276502A1 Compositions for the prevention and treatment of neuroinjury and methods of use thereof |
| 01/26/2011 | EP2276501A2 Methods and compositions for genetic and retinal disease |
| 01/26/2011 | EP2276500A2 Reactivation of axon growth and recovery in chronic spinal cord injury |
| 01/26/2011 | EP2276499A2 Recombinant deamidated gliadin antigen |
| 01/26/2011 | EP2276497A1 Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication |
| 01/26/2011 | EP2276496A1 Therapeutic modulation of ocular surface lubrication |
| 01/26/2011 | EP2276463A2 Diterpene glycosides as natural solubilizers |
| 01/26/2011 | EP2276458A1 Liquid buffered gdf-5 formulations |
| 01/26/2011 | EP1912665B1 Vaccine against feline calicivirus (fcv) comprising a fcv capsid protein or an isolated fcv capsid protein comprising protein sequence seq id no: 13 or protein sequences having at least 95% identity thereto. |
| 01/26/2011 | EP1907419B1 Preparation of insulin conjugates |
| 01/26/2011 | EP1842066B1 Biologically active silver-coated proteins |
| 01/26/2011 | EP1817337B1 Therapeutic peptides comprising sequences derived from cdr2 or cdr3 of trem-1 and uses thereof to inhibit sepsis |
| 01/26/2011 | EP1725261B1 Use of agonists and antagonists of interleukin-33 (il-33) |
| 01/26/2011 | EP1615612B1 Pro-urokinase mutant for lysis of occlusive blood clots while sparing wound sealing clots in the treatment of stroke |
| 01/26/2011 | EP1581649B1 Binding agents which inhibit myostatin |
| 01/26/2011 | EP1578778B1 Ghrelin analogs |
| 01/26/2011 | EP1556489B1 Pharmaceutical composition for preparing a medicine for treating and/or preventing a pathology related to an obsessive behaviour or obesity |
| 01/26/2011 | EP1539956B1 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/26/2011 | EP1404365B1 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 01/26/2011 | EP1365769B1 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
| 01/26/2011 | EP1303186B1 Medicinal uses of mu-opioid receptor agonists |
| 01/26/2011 | EP1192180B1 Product from starfish |
| 01/26/2011 | EP1002051B1 Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom |
| 01/26/2011 | EP0948625B1 Uspa1 and uspa2 antigens of moraxella catarrhalis |
| 01/26/2011 | EP0946725B1 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
| 01/26/2011 | CN1799623B Use of No. 21 biological active peptide in preparation of medicine for preventing and treating arthritis |
| 01/26/2011 | CN1775284B Blood-viscosity reducing agent |
| 01/26/2011 | CN101960307A High-molecular-weight adiponectin measurement method |
| 01/26/2011 | CN101959900A Glycosylated glycopeptide antibiotic derivative |
| 01/26/2011 | CN101959532A Pharmaceutical composition for transnasal administration |
| 01/26/2011 | CN101959530A Prophylactic or therapeutic agent for diabetes or obesity |
| 01/26/2011 | CN101959526A Use of interleukin-1 conjugates in the treatment of diabetes |
| 01/26/2011 | CN101955997A Compositions and method for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 01/26/2011 | CN101955942A DNA (Deoxyribonucleic Acid) molecule for encoding pig alpha-interferon and recombinant colibacillus as well as application thereof |
| 01/26/2011 | CN101955543A Nerve growth factor bound with laminin, and coding gene and application thereof |
| 01/26/2011 | CN101955527A Novel insulin derivatives |
| 01/26/2011 | CN101955525A Artificial antimicrobial peptide, gene and preparation method thereof |
| 01/26/2011 | CN101955524A CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
| 01/26/2011 | CN101955523A Preparation and application of Eriocheir sinensis whey acidic protein (WAP) with bacteriostatic activity |
| 01/26/2011 | CN101955512A Angiotensin I converting enzyme activity inhibiting oligopeptides as well as preparation method and application thereof |
| 01/26/2011 | CN101954072A Use of ulinastatin in preparation of drugs for treating rheumatoid arthritis and pharmaceutical composition thereof |
| 01/26/2011 | CN101954071A Use of ulinastatin in preparation of medicament for treating systemic lupus erythematosus and medicinal composition of ulinastatin |
| 01/26/2011 | CN101954070A Preparation method of composition of nano SOD and vegetable drugs and health-care food or extracts thereof |
| 01/26/2011 | CN101954069A Anticancer application of recombinant human manganese superoxide dismutase |
| 01/26/2011 | CN101954068A Combined medicament for treating prostatitis and preparation method thereof |
| 01/26/2011 | CN101954067A Aqueous solution of recombinant human serum albumin-interferon alpha fusion protein and preparation method thereof |
| 01/26/2011 | CN101954066A Medicament for promoting repair of peripheral nerve injury |
| 01/26/2011 | CN101954065A Recombinant human endostatin nanoparticle composition for injection and preparation method thereof |
| 01/26/2011 | CN101954064A Composition for whitening and removing spots and preparation method thereof |
| 01/26/2011 | CN101953857A Compound fermented cordyceps sinensis bacterium powder (paecilomyces hepiali Cs-4 bacterium powder) composite medicine |
| 01/26/2011 | CN101953796A Method for preparing recombinant human endostatin chitosan nanoparticles for injection |
| 01/26/2011 | CN101953784A Veterinary suspension containing amoxicillin, colistin sulfate and prednisolone and preparation method thereof |
| 01/26/2011 | CN101953319A Transgenic animal over-expressing cardiac ankyrin repeat protein as well as production method and application thereof |
| 01/26/2011 | CN101559039B Method for producing nattokinase liposome from phytosterol |
| 01/26/2011 | CN101481691B Trichinella spiralis 70KDa heat shock protein and use thereof |
| 01/26/2011 | CN101297821B Phellinus linteus mycelia active glucoprotein and use thereof and preparation |
| 01/26/2011 | CN101240014B Lipopeptid composition with physiological activity and its preparation method and application |
| 01/26/2011 | CN101172997B Oligopeptide or its modified compound/derivant and application thereof |
| 01/26/2011 | CN101139399B Fused protein restructuring target lethal leukemia cells and preparation method and use thereof |
| 01/26/2011 | CN101077875B Boronic ester and acid compounds, synthesis and uses |
| 01/25/2011 | USRE42072 High transport rates of hormones delivered across cell membranes, facilitating more efficient delivery of drugs and diagnostic agents by using a viscous fluid comprising a polysaccharide a form of hydrogel, lipogel or sols; drug delivery to mucous membranes; gastrointesinal systems |
| 01/25/2011 | US7875710 Nucleic acids encoding platelet derived growth factor receptor alpha (PDGFRA) activating mutations |
| 01/25/2011 | US7875709 Nucleic acids encoding interleukin-18 mutants |
| 01/25/2011 | US7875703 Comprises nucleotide sequences coding antibody receptor for treating autoimmune and immunological diseases |
| 01/25/2011 | US7875701 Diagnostic compounds |
| 01/25/2011 | US7875700 Cation complexes of insulin compound conjugates, formulation and uses thereof |
| 01/25/2011 | US7875677 Micellar drug delivery systems for hydrophobic drugs |
| 01/25/2011 | US7875591 comprising a scaffold coated with a protein having at least 83% identity to the amino acid sequence of the core protein of domain I of a mammalian perlecan, wherein at least one glycosaminoglycan is attached to the protein; induce replication and/or differentiation of connective tissue cells |
| 01/25/2011 | US7875590 using an injectable or implantable rod-shaped formulation for delivery of osteogenic proteins to treat osteoporotic and/or osteopenic bone; bone morphogenic proteins |
| 01/25/2011 | US7875589 Alpha B-crystallin as a therapy for rheumatoid arthritis |
| 01/25/2011 | US7875588 Methods of therapy using pharmaceutical composition for thrombin peptide derivatives |
| 01/25/2011 | US7875587 such as type 2 diabetes, obesity, insulin resistance; stimules insulin release; dipeptidyl peptidase-IV resistant gastric inhibitory peptide (GIP) analog |
| 01/25/2011 | US7875586 Treatment of metastatic colon cancer with b-subunit of shiga toxin |
| 01/25/2011 | US7875585 Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptide |
| 01/25/2011 | US7875450 Virus-like particles for the induction of autoantibodies |
| 01/25/2011 | US7875436 immobilization; solid phase synthesis; kits |
| 01/25/2011 | US7875342 Porous ceramic composite bone grafts |
| 01/25/2011 | US7875310 Residual solvent extraction method and microparticles produced thereby |
| 01/25/2011 | US7875289 Compositions of less immunogenic and long-circulating protein-lipid complexes |
| 01/25/2011 | US7875288 such as hemophilia, by administering lipidic nanoparticles comprising phosphatidylcholine, phosphatidylinositol and cholesterol; use when the individual has developed the side effect of antibodies to Factor VIII |
| 01/25/2011 | US7875279 intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis are enriched by deleting or inactivating genes; asthma, morbus Crohn, colitis ulcerosa, multiple sclerosis and chronic bronchitis and immune and auto-immune diseases and allergies and bone diseases and osteoporosis |
| 01/25/2011 | US7875259 Generating prion specific immunoglobulin for use in diagnosis, prevention and treatment of neurodegenerative disorders |
| 01/25/2011 | CA2635963C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 01/25/2011 | CA2541599C Blister pack and solid dosage form therefor |
| 01/25/2011 | CA2525499C Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 01/25/2011 | CA2495743C Fusion proteins and methods of producing same |
| 01/25/2011 | CA2477557C Stabilized albumin preparations |
| 01/25/2011 | CA2453278C Diagnostic agents for pancreatic exocrine function |
| 01/25/2011 | CA2436599C Oral pharmaceutical compositions comprising polyvinylpyrrolidone (pvp) and 5-cnac |
| 01/25/2011 | CA2428937C Method for treating respiratory distress syndrome using leptin |
| 01/25/2011 | CA2405030C Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 01/25/2011 | CA2385322C A substantially cell membrane impermeable compound and use thereof |
| 01/25/2011 | CA2378519C Human cytokine receptor |
| 01/25/2011 | CA2369826C Therapy of cardiac insufficiency |
| 01/25/2011 | CA2355768C Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 01/25/2011 | CA2344467C Ucp4 |
| 01/25/2011 | CA2340786C Vaccine comprising cytokine-induced heat shock proteins (hsp) |
| 01/25/2011 | CA2339834C Water soluble prodrugs of hindered alcohols or phenols |